S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL

Bibliographic Details
Published in:HemaSphere
Main Authors: M Heeney, D Rees, M de Montalembert, I Odame, C Brown, Y Wali, T Nguyen, D Lam, N Pfender, J Kanter
Format: Article
Language:English
Published: Wiley 2022-01-01
Online Access:http://journals.lww.com/10.1097/01.HS9.0000821456.11824.0b